Loading...
Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases
High dose cyclophosphamide (HiCY) without stem cell rescue has been shown to induce remissions in patients with severe autoimmune disorders (SADS). However, up to 80% of these patients ultimately relapse. Here we review the outcomes of seven patients treated with two cycles and one patient treated w...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
e-Century Publishing Corporation
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3555191/ https://ncbi.nlm.nih.gov/pubmed/23358715 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|